Cited by 487Hormonal and reproductive studiesAdipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Testosterone and obesity

Kelly, D. M., Jones, T. H.·2015·Obesity Reviews

Abstract

Summary: Testosterone is a key hormone in the pathology of metabolic diseases such as obesity. Low testosterone levels are associated with increased fat mass (particularly central adiposity) and reduced lean mass in males. These morphological features are linked to metabolic dysfunction, and testosterone deficiency is associated with energy imbalance, impaired glucose control, reduced insulin sensitivity and dyslipidaemia. A bidirectional relationship between testosterone and obesity underpins this association indicated by the hypogonadal–obesity cycle and evidence weight loss can lead to increased testosterone levels. Androgenic effects on enzymatic pathways of fatty acid metabolism, glucose control and energy utilization are apparent and often tissue specific with differential effects noted in different regional fat depots, muscle and liver to potentially explain the mechanisms of testosterone action. Testosterone replacement therapy demonstrates beneficial effects on measures of obesity that are partially explained by both direct metabolic actions on adipose and muscle and also potentially by increasing motivation, vigour and energy allowing obese individuals to engage in more active lifestyles. The degree of these beneficial effects may be dependent on the treatment modality with longer term administration often achieving greater improvements. Testosterone replacement may therefore potentially be an effective adjunctive treatment for weight management in obese men with concomitant hypogonadism.

Integrity signals

Registry

Crossref · 10.1111/obr.12282

Cites

339 of 339 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multiple groups have observed a significant negative association between obesity and testosterone levels.

    “A significant negative association has also been observed between obesity and T levels by multiple groups,72-74 emphasizing the metabolic importance of maintaining T production with age.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kelly, D. M., & Jones, T. H.
Affiliations
  • University of Sheffield (GB)
  • Barnsley Hospital NHS Foundation Trust (GB)
Corresponding author
Kelly, D. M.
Venue
Obesity Reviews
Publisher
Wiley
Published
2015-05-15
Volume
16
Issue
7
Pages
581-606
ISSN
  • 1467-7881 (ISSN-L)
  • 1467-789X
OpenAlex
W1917696566
Cited by
487
References
339
Citations by year
2026: 43 · 2025: 62 · 2024: 61 · 2023: 54 · 2022: 62 · 2021: 43 · 2020: 45 · 2019: 32 · 2018: 33 · 2017: 31 · 2016: 13 · 2015: 6
FWCI
4.16
Type
journal article
Language
en
Open access
closed
Locations
  • Obesity Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University) (submittedVersion)
Funders
Bayer HealthCare
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
testosterone, obesity, hypogonadism, testosterone replacement therapy, abdominal obesity, fat mass, lean body mass, insulin sensitivity, glycemic control, dyslipidemia, energy balance, weight management
MeSH terms
Adipose Tissue, Adult, Humans, Hypogonadism, Male, Obesity, Receptors, Androgen, Risk Factors, Testosterone, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review